These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 2515212)

  • 1. Experience with a new fixed-stimulation protocol without hormone determinations for programmed oocyte retrieval for in-vitro fertilization.
    Kemeter P; Feichtinger W
    Hum Reprod; 1989 Nov; 4(8 Suppl):53-8. PubMed ID: 2515212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fixed stimulation protocol for in vitro fertilization (IVF) without determinations of hormones in blood.
    Kemeter P; Feichtinger W
    Acta Eur Fertil; 1989; 20(2):63-70. PubMed ID: 2508391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of different ovarian stimulation protocols for in vitro fertilization.
    Pados G; Tarlatzis BC; Bontis J; Lagos S; Papadimas J; Spanos E; Mantalenakis S
    Gynecol Endocrinol; 1995 Jun; 9(2):103-12. PubMed ID: 7502685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro fertilisation. A review of drug therapy and clinical management.
    Jennings JC; Moreland K; Peterson CM
    Drugs; 1996 Sep; 52(3):313-43. PubMed ID: 8875126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The synergistic effects of clomiphene citrate and human menopausal gonadotrophin in the folliculogenesis of stimulated cycles as assessed by the gonadotrophin-releasing hormone antagonist Nal-Glu.
    Cassidenti DL; Paulson RJ; Lobo RA; Sauer MV
    Hum Reprod; 1992 Mar; 7(3):344-8. PubMed ID: 1587939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship among serum levels of luteinizing hormone, estradiol, and progesterone during follicle stimulation and results of in vitro fertilization and embryo transfer (IVF-ET).
    Kagawa T; Yamano S; Nishida S; Murayama S; Aono T
    J Assist Reprod Genet; 1992 Apr; 9(2):106-12. PubMed ID: 1627924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
    Jiang S; Kuang Y
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous luteinizing hormone surge during superovulation induction with sequential use of clomiphene citrate and pulsatile human menopausal gonadotropin.
    Messinis IE; Templeton A; Baird DT
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1076-80. PubMed ID: 3932447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear maturity and oocyte morphology after stimulation with highly purified follicle stimulating hormone compared to human menopausal gonadotrophin.
    Imthurn B; Macas E; Rosselli M; Keller PJ
    Hum Reprod; 1996 Nov; 11(11):2387-91. PubMed ID: 8981116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of gonadotropin releasing hormone agonist (GnRHa) in good responders undergoing repeat in vitro fertilization/embryo transfer (IVF/ET).
    Segars JH; Hill GA; Bryan SH; Herbert CM; Osteen KG; Rogers BJ; Wentz AC
    J In Vitro Fert Embryo Transf; 1990 Dec; 7(6):327-31. PubMed ID: 2127603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simplification of the method of in vitro fertilization: sonographic measurements of follicular diameter as the sole index of follicular maturity.
    Nilsson L; Wikland M; Hamberger L; Hillensjö T; Chari S; Sturm G; Daume E
    J In Vitro Fert Embryo Transf; 1985 Mar; 2(1):17-22. PubMed ID: 3926921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
    Hohmann FP; Macklon NS; Fauser BC
    J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin F2 alpha, progesterone and estradiol concentrations in human follicular fluid and their relation to success of in vitro fertilization.
    Suchanek E; Simunic V; Macas E; Kopjar B; Grizelj V
    Eur J Obstet Gynecol Reprod Biol; 1988 Aug; 28(4):331-9. PubMed ID: 3139478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of pure FSH alone or in combination for ovulation stimulation in in vitro fertilization.
    Acosta AA; Bernardus RE; Jones GE; Garcia J; Rosenwaks Z; Simonetti S; Veeck LL; Jones D
    Acta Eur Fertil; 1985; 16(2):81-99. PubMed ID: 3929523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clomiphene-HMG ovarian stimulation in human in vitro fertilization and embryo transfer].
    Oda T; Yoshimura S; Sumi Y; Shiina M; Yahagi M; Matsumoto C; Ohno T; Hara S; Nakamura Y; Iizuka R
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Oct; 37(10):2059-66. PubMed ID: 3935741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superovulation strategy before in vitro fertilization.
    Hillier SG; Afnan AM; Margara RA; Winston RM
    Clin Obstet Gynaecol; 1985 Sep; 12(3):687-723. PubMed ID: 3933880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trial of follicle stimulating hormone versus human menopausal gonadotrophin in in-vitro fertilization.
    Daya S; Gunby J; Hughes EG; Collins JA; Sagle MA
    Hum Reprod; 1995 Jun; 10(6):1392-6. PubMed ID: 7593503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Programmed ovulation induction and oocyte retrieval for in vitro fertilization.
    Salat-Baroux J; Antoine JM; Alvarez S; Cornet D; Tibi C; Mandelbaum J; Plachot M
    J In Vitro Fert Embryo Transf; 1988 Jun; 5(3):153-7. PubMed ID: 3139804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
    Vuong TN; Phung HT; Ho MT
    Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.